Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Brain Metastases
Interventions: DRUG: Lapatinib|PROCEDURE: Whole Brain Radiation|DRUG: Herceptin
Sponsor: Nancy Lin, MD
Collaborators: Brigham and Women's Hospital|Breast Cancer Research Foundation|GlaxoSmithKline